Pancreatic Cancer: New Cell Therapy Boosts Survival

For decades, pancreatic cancer has remained a stubbornly resistant foe, offering patients and their families a grim prognosis. Now, a promising new immune cell therapy is emerging from clinical trials, offering a genuine shift in the landscape of treatment and, crucially, hope. This isn’t just another incremental improvement; it represents a fundamentally different approach to … Read more

Glioblastoma: New Immunotherapy Targets Discovered by MIT

Glioblastoma, the most aggressive form of brain cancer, has long defied effective treatment. While immunotherapy has revolutionized cancer care for many tumor types, glioblastoma has remained stubbornly resistant. Now, a groundbreaking study from MIT’s Koch Institute offers a crucial new understanding of *why* this resistance exists – and, more importantly, identifies potential pathways to overcome … Read more